As trials expand into new geographies and decentralized models mature, sponsors are confronting a core operational challenge in 2026: how to scale global execution while reducing system complexity and ...

For years, health researchers have been talking about the potential of real-world data (RWD) to revolutionize every stage of clinical research, from trial design to outcomes measurement. Healthcare ...

Clinical psychology has long recognized that psychological distress and therapeutic change involve more than cognitive processes alone. Emotion regulation, ...

In a recent perspective published in Nature Medicine, the researcher shared his vision and future perspectives for the domains of clinical research and evidence-based therapeutics. In recent times, ...

BOSTON, Mass. – January 11, 2021 – NEJM Group today announces the launch of a new digital journal, NEJM Evidence, coming at a time when research transparency is being openly discussed in the medical ...

Pathkey has entered a master collaboration agreement (MCA) with Armstrong Clinical, a clinical development consultancy in Melbourne, Australia. This partnership aims to leverage Pathkey’s predictive ...

Walgreens sees a long runway for its two-year-old clinical trials business as it doubles down on its core retail pharmacy operations. Ramita Tandon, chief clinical trials officer, shared insights ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. Health technology startup HumanFirst is changing the way clinical ...

Traditional clinical trial data are pseudonymized data, and these data may not contain information on a patient that directly identifies them, like a name, address, or phone number. However, ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.